Work

A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer

Year: 2015

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-015-0293-8

Authors: Paul L. Swiecicki, Lili Zhao, Emily Belile, Assuntina G. Sacco, Douglas B. Chepeha, Irina Dobrosotskaya, Matthew Spector, Andrew Shuman, Kelly Malloy, Jeffrey Moyer, Erin McKean, Scott McLean, Gregory T. Wolf, Avraham Eisbruch, Mark Prince, Carol Bradford, Thomas Carey, Francis P. Worden

Institutions: University of Michigan, U-M Rogel Cancer Center, Moores Cancer Center, Henry Ford Hospital

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Comprehensive Cancer Network

OpenAlex ID: W1913970044

FWCI: 3.187

Cites: 31

Cited by: 43

Related to: 10